ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TCRX TScan Therapeutics Inc

8.8401
0.1901 (2.20%)
Last Updated: 12:56:53
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 2.85M3.02M4.06M3.36M3.1M6.8M3.15M3.89M
Operating Income -14.2M-16.16M-15.25M-16.58M-18.65M-22.74M-24.61M-24.75M
Pre Tax Income -14.2M-16.16M-15.1M-16.25M-18.72M-22.56M-24.05M-23M
Net Income -14.2M-16.16M-15.1M-16.25M-18.72M-22.56M-24.05M-23M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -14.2M-16.16M-15.1M-16.04M-17.75M-21.61M-24.61M-24.75M
EBITDA -13.06M-14.97M-14.04M-15.33M-17.17M-21.24M-23.31M-23.46M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 01.09M10.14M13.54M21.05M
Operating Income -14.21M-26.23M-48.64M-66.64M-93.46M
Pre Tax Income -13.66M-26.23M-48.63M-66.22M-89.22M
Net Income -13.66M-26.23M-48.63M-66.22M-89.22M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -2.591-4.976-2.034-1.367-0.933
EBIT -14.21M-26.23M-48.63M-65.05M-85.46M
EBITDA -13.69M-25M-45.31M-61.5M-88.1M

Your Recent History

Delayed Upgrade Clock